The emerging therapy of the medication represents a exciting development in the management of type 2 diabetes. Different to existing drugs, tirzepatide affects dual pathways – GLP-1 and the GIP hormone – providing enhanced sugar regulation and possible weight loss. Researchers are studying its future effects and role in the complete diabetes tr